Kerc; Janez

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kerc; Janez.The latest application filed is for "spray-freeze drying of polyelectrolyte nanoparticles containing the protein drug".

Company Profile

1.11.21

Kerc; Janez - Ljubljana SI
Kerc; Janez - Ljubinjana SI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Coated particles and pharmaceutical dosage forms Grant 9,907,757 - Humar , et al. March 6, 2	2018-03-06
Spray-Freeze Drying of Polyelectrolyte Nanoparticles Containing the Protein Drug App 20170258726 - CEGNAR; Mateja ; et al.	2017-09-14
Coated Particles And Pharmaceutical Dosage Forms App 20160128946 - Humar; Vlasta ; et al.	2016-05-12
Coated particles and pharmaceutical dosage forms Grant 9,149,460 - Humar , et al. October 6, 2	2015-10-06
Process for the preparation of a pharmaceutical composition comprising ezetimibe Grant 9,089,486 - Kerc , et al. July 28, 2	2015-07-28
Self-microemulsifying drug delivery systems Grant 8,592,490 - Legen , et al. November 26, 2	2013-11-26
Process For The Preparation Of A Pharmaceutical Composition Comprising Ezetimibe App 20120135976 - Kerc; Janez ; et al.	2012-05-31
Pharmaceutical Composition Comprising Ezetimibe And Simvastatin App 20120027854 - Homar; Miha ; et al.	2012-02-02
Self-microemulsifying Systems Incorporated Into Liquid Core Microcapsules App 20110111042 - Kerc; Janez ; et al.	2011-05-12
Preparation Of Nanoparticles By Using A Vibrating Nozzle Device App 20110068497 - Ahlin Grabnar; Pegi ; et al.	2011-03-24
Controlled Release Tamsulosin Hydrochloride Tablets And A Process Of Making Them App 20110033534 - Kerc; Janez ; et al.	2011-02-10
Self-microemulsifying Drug Delivery Systems App 20100331356 - Legen; Igor ; et al.	2010-12-30
Gastroresistant Pharmaceutical Dosage Form Comprising N-(2-(2- Phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic Acid (lk-423) App 20100183714 - Bogataj; Marija ; et al.	2010-07-22
Hot-melt Micropellets App 20100172969 - Dreu; Rok ; et al.	2010-07-08
Stable Pharmaceutical Formulation Comprising A Hmg-coa Reductase Inhibitor App 20090264497 - Kerc; Janez	2009-10-22
Modified release pharmaceutical composition Grant 7,485,322 - Kerc February 3, 2	2009-02-03
Pharmaceutical Composition App 20080242725 - Kerc; Janez ; et al.	2008-10-02
Pharmaceutical Multiparticulate Composit Ion Comprising Mycophenolic Acid or Myco Phenolate Sodium and Combination Compositions with Rapamycin App 20080206322 - Becker; Dieter ; et al.	2008-08-28
Coated Particles and Pharmaceutical Dosage Forms App 20080138429 - HUMAR; Vlasta ; et al.	2008-06-12
Pharmaceutical compositions comprising amoxicillin and clavulanic acid App 20060159741 - Kerc; Janez ; et al.	2006-07-20
Therapeutic system comprising amoxicillin and clavulanic acid App 20060121106 - Kerc; Janez ; et al.	2006-06-08
Coated particles and pharmaceutical dosage forms App 20060093680 - Humar; Vlasta ; et al.	2006-05-04
Controlled release pharmaceutical formulation containing venlafaxine App 20050042290 - Kerc, Janez ; et al.	2005-02-24
Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same Grant 6,806,290 - Pflaum , et al. October 19, 2	2004-10-19
Modified release pharmaceutical composition App 20040131669 - Kerc, Janez	2004-07-08
Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor App 20040072894 - Kerc, Janez	2004-04-15
Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor Grant 6,680,341 - Kerc January 20, 2	2004-01-20
Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same App 20030109584 - Pflaum, Zlatko ; et al.	2003-06-12
Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application Grant 6,042,847 - Kerc , et al. March 28, 2	2000-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.